La Mesa, CANCT05156398Now EnrollingIRB Ready

Pediatric Migraine Clinical Trial in La Mesa, CA

Access cutting-edge pediatric migraine treatment through this phase 3 clinical trial at a research site in La Mesa. Study-provided care at no cost to qualified participants.

Sponsored by Pfizer

Quick Self-Assessment

See if you qualify for this La Mesa location

Preparing your pre-screening questions…

Expert Care in La Mesa

Access pediatric migraine specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related pediatric migraine treatment provided free

Apply for This La Mesa Location

Check if you qualify for this pediatric migraine clinical trial in La Mesa, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to La Mesa

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit La Mesa site if eligible
  4. 4Begin participation

About This Pediatric Migraine Study in La Mesa

The purpose of this study is to compare the efficacy and safety of rimegepant to placebo as a preventative treatment for migraine in children and adolescents ≥ 6 to \<18 years with episodic migraine.

Sponsor: Pfizer

Who Can Participate

Inclusion Criteria

Subject has at least a 6 month history of migraine (with or without aura) and including the following:
14 or less headache days per month during the 3 month period prior to the Screening Visit
6 or more migraine days during the Observation Period
14 or less headache days during the Observation Period
Pediatric Migraine Disability Assessment Scale (PedMIDAS) Disability Score of \>10 to ≤50, indicating mild (score of 11 to 30) or moderate (score of 31 to 50) disruption in daily activities, as assessed at the Baseline (Randomization) Visit
Ability to verbally distinguish migraine attacks from tension/cluster or other types of headaches
Migraine attacks, on average, lasting 4 - 72 hours if untreated
Subjects on prophylactic migraine medication are permitted to remain on therapy if the dose has been stable for at least 3 months (12 weeks) prior to the Screening Phase, and the dose is not expected to change during the course of the study. 2) Male and female subjects ≥ 6 to \<18 years; subjects must be less than 18 at the time of signing assent / consent. 3)Subjects must have a weight of ≥40 kg (child cohort requirement ≥15 kg) at the Screening Visit.

Exclusion Criteria

Subjects with a history of basilar migraine, cluster headaches, or hemiplegic migraine
The subject has a continuous migraine (defined as an unrelenting headache) within 1 month prior to Screening Visit.
The subject has a history or diagnosis of complications of migraine
The subject has a confounding and clinically significant pain syndrome that may interfere with the subject's ability to participate in this study.
The subject has any current psychiatric condition that is uncontrolled and/or untreated for a minimum of 6 months prior to the Screening Visit. Subjects with a lifetime history of psychosis and/or mania are excluded.
History of suicidal behavior or the subject is at risk of self-harm or harm to others.
History of major psychiatric disorder.
The subject has a current diagnosis or history of substance abuse
The subject has a history of moderate or severe head trauma or other neurological disorder (including seizure disorder) or systemic medical disease that is, in the investigator's opinion, likely to affect central nervous system functioning.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in La Mesa?

Yes, this clinical trial (NCT05156398) has an active research site in La Mesa, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Pediatric Migraine Treatment Options in La Mesa, CA

If you're searching for pediatric migraine treatment options in La Mesa, CA, this clinical trial (NCT05156398) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our La Mesa research site is actively enrolling participants for this phase 3 clinical trial. You'll receive care from experienced pediatric migraine specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all pediatric migraine clinical trials near you to find additional studies recruiting in your area.

More Heart Attack Trials in La Mesa, CA

See all heart attack clinical trials recruiting in La Mesa — not just this study.

Browse Heart Attack Trials in La Mesa →

Browse More Trials by Condition

Heart Attack TrialsPulmonary Embolism TrialsMigraine TrialsRheumatoid Arthritis TrialsErectile Dysfunction TrialsInterstitial Cystitis TrialsMyocardial Infarction TrialsAll Conditions →

Ready to Join in La Mesa?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · La Mesa, CA